Neurologic complications of ovarian carcinoma

Cancer

Volumn 85, Issue 1, 1999, Pages 127-133

  Abrey, Lauren E ^a   Dalmau, Josep O ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Brain; Cerebrovascular disorders; Iatrogenic disease; Metastasis; Ovarian neoplasms; Paraneoplastic; Syndrome

Indexed keywords

ADOLESCENT; AGED; ARTICLE; BRAIN METASTASIS; CEREBROVASCULAR DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; IATROGENIC DISEASE; INSTITUTIONAL CARE; MAJOR CLINICAL STUDY; MENTAL HEALTH; OVARY CARCINOMA; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; IATROGENIC DISEASE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; NERVOUS SYSTEM NEOPLASMS; OVARIAN NEOPLASMS; PARANEOPLASTIC SYNDROMES;

EID: 0032896130     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990101)85:1<127::AID-CNCR18>3.0.CO;2-7     Document Type: Article

References (22)

1. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. American Joint Commission on Cancer manual for staging of cancer. 4th edition. Philadelphia: J.B. Lippincott Co., 1992:155-79.
2. Posner JB. Neurologic complications of cancer. Philadelphia: F.A. Davis, 1995.
3. Graus F, Rogers LR, Posner JB. Cerebrovascular complications in patients with cancer. Medicine (Baltimore) 1985;64: 16-35.
4. Gordon AN, Stringer CA, Matthews CM, Willis DL, Nemunaitis J. Phase I dose escalation of paclitaxel in patients with advanced ovarian cancer receiving cisplatin: rapid development of neurotoxicity is dose-limiting. J Clin Oncol 1997;15: 1965-73.
5. Cavaletti G, Bogliun G, Marzorati L, Zincone A, Marzola M, Colombo N, et al. Peripheral neuropathy of taxol in patients previously treated with cisplatin. Cancer 1995;75:1141-50.
6. Watkin SW, Husband DJ, Green JA, Warenius HM. Ifosfamide encephalopathy: a reappraisal. Eur J Cancer Clin Oncol 1989;25:1303-10.
7. Apfel SC, Arezzo JC, Lipson L, Kessler JA. Nerve growth factor prevents experimental cisplatin neuropathy. Ann Neurol 1992;31:76-80.
8. Mollman JE, Glover DJ, Hogan WM, Furman RE. Cisplatin neuropathy risk factors, prognosis, and protection by WR 27721. Cancer 1988;61:2192-5.
9. Van Der Hoop RG, Vecht CJ, Van Der Burg MEL, Elderson A, Boogerd W, Heimans JJ, et al. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer. N Engl J Med 1990;322:89-94.
10. Larson D, Copeland L, Moser R, Malone JM Jr., Gershenson DM, Wharton JT, et al. Central nervous system metastases in epithelial ovarian cancer. Obstet Gynecol 1986;68:746-50.
11. Dauplat J, Nieberg RK, Hacker NF. Central nervous system metastases in epithelial ovarian cancer. Cancer 1987;60: 2559-62.
12. Stein M, Steiner M, Klein B, Beck D, Atad J, Kuten A, et al. Involvement of the central nervous system by ovarian carcinoma. Cancer 1986;58:2066-8.
13. Deutsch M, Beck D, Manor D, Brandes J. Metastatic brain tumor following second look operation in ovarian carcinoma. Gynecol Oncol 1987;27:116-20.
14. Ross WM, Carmichael VA, Shelley WE. Advanced carcinoma of the ovary with central nervous system relapse. Gynecol Oncol 1988;30:398-406.
15. Ziegler J, Gliedman P, Fass D, Beckman M, Neophytides A, Steinfeld A. Brain metastases from ovarian cancer. J Neurooncol 1987;5:211-5.
16. Mayer RJ, Berkowitz R, Griffiths T. Central nervous system involvement by ovarian carcinoma: a complication of prolonged survival with metastatic disease. Cancer 1978;41: 776-83.
17. Le Roux PD, Berger MS, Elliott P, Tamimi HK. Cerebral metastases from ovarian carcinoma. Cancer 1991;67:2194-9.
18. Barker GH, Orledge J, Wiltshaw E. Involvement of the central nervous system in patients with ovarian carcinoma. Br J Obstet Gynaecol 1981;88:690-4.
19. Rodriguez GC, Soper IT, Berchuck A, Oleson J, Dodge R, Montana G, et al. Improved palliation of cerebral metastases in epithelial ovarian cancer using a combined modality approach including radiation therapy, chemotherapy and surgery. J Clin Oncol 1992;10:1553-60.
20. Delattre JY, Krol G, Thaler HT. Distribution of brain metastases. Arch Neurol 1988;45:741-4.
21. Ashour AA, Verschragen CF, Kudlelka AP, Kavanagh JJ. Paraneoplastic syndromes of gynecologic neoplasms. J Clin Oncol 1997;15:1272-82.
22. Furneaux HM, Rosenblum MK, Dalmau J, Wong E, Woodruff P, Graus F, et al. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration. N Engl J Med 1990;322: 1844-51.